The Mevalonate Pathway and Innate Immune Hyper-Responsiveness in the Pathogenesis of COPD and Lung Cancer: Potential for Chemoprevention

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|10|1|46-59

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.10, Iss.1, 2017-01, pp. : 46-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Cancer Therapy: Targeting the Mevalonate Pathway

By  

Current Cancer Drug Targets, Vol. 6, Iss. 1, 2006-02 ,pp. : 15-37

Bentham Science Publishers

Access to resources Recommend Favorite

Potential use of lipoxygenase inhibitors for cancer chemoprevention

By Steele V.E.   Holmes C.A.   Hawk E.T.   Kopelovich L.   Lubet R.A.   Crowell J.A.   Sigman C.C.   Kelloff G.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 9, 2000-09 ,pp. : 2121-2138

Informa Healthcare

Access to resources Recommend Favorite

The Potential of Statins for Individualized Colorectal Cancer Chemoprevention

By  

Current Drug Targets, Vol. 12, Iss. 13, 2011-12 ,pp. : 1903-1908

Bentham Science Publishers

Access to resources Recommend Favorite

The role of inflammation in the pathogenesis of lung cancer

By Cho William CS   Kwan Chung K   Yau Stephen   So Peter PF   Poon Patricia CM   Au Joseph SK  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 9, 2011-09 ,pp. : 1127-1137

Informa Healthcare

Access to resources Recommend Favorite

Five-Lipoxygenase Pathway of Arachidonic Acid Metabolism in Carcinogenesis and Cancer Chemoprevention

By  

Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. : 613-622

Bentham Science Publishers

Access to resources Recommend Favorite